2030년까지 중남미 유방암 치료제 시장 예측 - 지역 분석 - 약물 치료[표적 약물 치료(Abemaciclib, Ado-Trastuzumab Emtansine, Palbociclib, Trastuzumab 및 기타 표적 약물 치료), 호르몬 약물 치료(선택적 에스트로겐 수용체 조절제, 아로마타제 억제제 및 선택적 에스트로겐 수용체 하향조절제), 화학요법 및 면역요법/생물학적 요법], 유방암 유형(호르몬 수용체, HER2+ 및 삼중 음성 유방암) 및 유통 채널(병원 약국, 약국 및 소매 약국, 온라인 약국)
맞춤형 의약품 연료의 사용 증가, 중남미 유방암 치료제 시장
맞춤형 의약품에는 맞춤형 치료 계획이 포함됩니다 무엇보다도 유전적 구성을 바탕으로 개별 환자에게 적용됩니다. 이 접근법은 각 환자의 암의 고유한 특성을 고려하므로 고도로 표적화되고 효과적인 치료를 가능하게 합니다. 유전체학 및 분자 진단의 발전으로 맞춤형 의학이 유방암 치료에서 실행 가능한 옵션이 되었습니다. 의료 서비스 제공자는 환자의 종양을 분자 수준에서 분석하여 암 성장을 촉진하는 특정 유전적 돌연변이나 바이오마커를 식별할 수 있습니다. 그런 다음 이 정보를 사용하여 특정 환자에게 가장 효과적일 수 있는 표적 치료법이나 면역 치료법과 같은 가장 적절한 치료 옵션을 선택할 수 있습니다. 유방암 치료에 맞춤형 의약품을 사용하면 환자 결과를 크게 향상시킬 수 있는 잠재력이 있습니다. 예를 들어, 2022년 2월 NIH 연구자들은 환자의 종양과 싸우는 면역 세포를 사용하여 전이성 유방암 환자를 치료하는 실험적 형태의 면역요법인 맞춤형 유방암 치료법을 개발하여 맞춤형 의학을 발전시켰습니다.
남미 및 중미 유방암 치료제 시장 개요
남미 및 중미의 유방암 치료제 시장은 브라질, 아르헨티나 및 기타 중남미 지역으로 구분됩니다. 브라질은 이 지역에서 큰 비중을 차지할 것으로 예상됩니다. 또한 가장 높은 성장률을 기록할 것으로 예상된다. 유방암 발병률 증가, 인구 노령화, 1인당 의료비 지출 증가는 유방암 치료제 시장을 빠르게 촉진할 것으로 예상되는 요인 중 하나입니다.
브라질에서 유방암 유병률이 증가함에 따라 유방암 치료제에 대한 수요가 증가하고 있습니다. Nature Publications에 따르면 유방암은 브라질 여성에게 가장 흔한 악성 종양입니다. 브라질 국립 암 연구소(INCA)에 따르면, 매년 브라질에서 약 66,200명의 새로운 여성 유방암 사례가 확인되며, 이는 연령 표준화 발병률을 여성 100,000명당 43.74명으로 환산합니다.
브라질의 의료 인프라 개선과 첨단 의료 기술에 대한 접근성도 시장을 주도하고 있습니다. 정부는 의료 시설을 확장하고 유방암 검진 및 치료를 포함한 의료 서비스에 대한 접근성을 향상시키는 데 투자해 왔습니다. 이로 인해 유방암 사례를 조기에 발견하고 치료제에 대한 수요가 증가했습니다. 따라서 유방암 유병률 증가, 의료 인프라 개선, 유방암 인식 제고는 브라질 유방암 치료제 시장을 이끄는 주요 요인입니다.
유방암 치료제 시장은 약물 치료, 유방암 유형 및 유통 채널을 기준으로 분류됩니다.
중남미 유방암 치료제 시장은 약물치료를 기준으로 표적 약물치료, 호르몬 약물치료, 화학요법, 면역치료/생물학적 치료 등으로 구분됩니다. 표적 약물 치료 부문은 2022년에 더 큰 점유율을 차지했습니다. 표적 약물 치료 부문은 2022년에 더 큰 점유율을 차지했습니다. 표적 약물 치료 부문은 abemaciclib, ado-trastuzumab emtansine, palbociclib, trastuzumab 및 기타 표적 약물 치료로 더 세분화됩니다. 또한 호르몬 약물 치료 부문은 선택적 에스트로겐 수용체 조절제, 아로마타제 억제제 및 선택적 에스트로겐 수용체 하향 조절제로 분류됩니다.
유방암 유형별로 보면 중남미 유방암 치료제 시장은 호르몬 수용체인 HER2+ 유방암과 삼중음성 유방암으로 구분된다. 2022년에는 호르몬 수용체 부문이 더 큰 점유율을 차지했습니다.
유통 채널별로 중남미 유방암 치료제 시장은 병원 약국, 약국, 소매 약국, 온라인 약국으로 분류됩니다. 2022년에는 병원 약국 부문이 더 큰 점유율을 차지했습니다.
국가별로 중남미 유방암 치료제 시장은 브라질, 아르헨티나, 중남미 나머지 지역으로 분류됩니다. 브라질은 2022년 중남미 유방암 치료제 시장을 장악했습니다.
Eli Lilly and Co, Eisai Co Ltd, Novartis AG, AstraZeneca Plc, Pfizer Inc, Gilead Sciences Inc, Merck & Co Inc, Teva Pharmaceutical Industries Ltd와 Amgen Inc는 중남미 유방암 치료제 시장에서 활동하는 선두 기업 중 일부입니다.
Table of Content
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. South & Central America Breast Cancer Therapeutics Market - Key Industry Dynamics
4.1 Key Market Drivers
4.1.1 Growing Burden of Breast Cancer
4.1.2 Launch of Several Diagnostics and Screening Programs
4.2 Key Market Restraints
4.2.1 High Cost of Diagnosis and Treatment
4.3 Key Market Opportunities
4.3.1 Increased Support from Government and Private Organizations
4.4 Key Future Trends
4.4.1 Increasing Use of Personalized Medicine
4.5 Impact Analysis:
5. Breast Cancer Therapeutics Market - South & Central America Market Analysis
5.1 South & Central America Breast Cancer Therapeutics Market Revenue (US$ Mn), 2022 - 2030
6. South & Central America Breast Cancer Therapeutics Market - Revenue and Forecast to 2030 - by Drug Therapy
6.1 Overview
6.2 South & Central America Breast Cancer Therapeutics Market Revenue Share, by Drug Therapy, 2022 & 2030 (%)
6.3 Targeted Drug Therapy
6.3.1 Overview
6.3.2 Targeted Drug Therapy: South & Central America Breast Cancer Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)
6.3.2.1 South & Central America Breast Cancer Therapeutics Market, by Targeted Drug Therapy, 2020-2030 (US$ Million)
6.4 Hormonal Drug Therapy
6.4.1 Overview
6.4.2 Hormonal Drug Therapy: South & Central America Breast Cancer Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)
6.4.2.1 South & Central America Breast Cancer Therapeutics Market, by Hormonal Drug Therapy, 2020-2030 (US$ Million)
6.5 Chemotherapy
6.5.1 Overview
6.5.2 Chemotherapy: South & Central America Breast Cancer Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)
6.6 Immunotherapy/ Biological Therapy
6.6.1 Overview
6.6.2 Immunotherapy/ Biological Therapy: South & Central America Breast Cancer Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)
7. South & Central America Breast Cancer Therapeutics Market - Revenue and Forecast to 2030 - by Breast Cancer Type
7.1 Overview
7.2 South & Central America Breast Cancer Therapeutics Market Revenue Share, by Breast Cancer Type, 2022 & 2030 (%)
7.3 Hormone Receptor
7.3.1 Overview
7.3.2 Hormone Receptor: South & Central America Breast Cancer Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)
7.4 HER2+ (human epidermal growth factor receptor 2)
7.4.1 Overview
7.4.2 HER2+: South & Central America Breast Cancer Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)
7.5 Triple-Negative Breast Cancer
7.5.1 Overview
7.5.2 Triple-Negative Breast Cancer: South & Central America Breast Cancer Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)
8. South & Central America Breast Cancer Therapeutics Market - Revenue and Forecast to 2030 - by Distribution Channel
8.1 Overview
8.2 South & Central America Breast Cancer Therapeutics Market Revenue Share, by Distribution Channel, 2022 & 2030 (%)
8.3 Hospital Pharmacies
8.3.1 Overview
8.3.2 Hospital Pharmacies: South & Central America Breast Cancer Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Drug Store and Retail Pharmacies
8.4.1 Overview
8.4.2 Drug Store and Retail Pharmacies: South & Central America Breast Cancer Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)
8.5 Online Pharmacies
8.5.1 Overview
8.5.2 Online Pharmacies: South & Central America Breast Cancer Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)
9. South & Central America Breast Cancer Therapeutics Market -Country Analysis
9.1 South & Central America Breast Cancer Therapeutics Market, Revenue and Forecast to 2030
9.1.1 Overview
9.1.2 South & Central America Breast Cancer Therapeutics Market, Breakdown, by Country -Revenue (2022) (US$ Million)
9.1.3 South & Central America Breast Cancer Therapeutics Market, By Countries, 2022 and 2030 (%)
9.1.3.1 Brazil
9.1.3.1.1 Brazil Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
9.1.3.1.2 Brazil: Breast Cancer Therapeutics Market, by Drug Therapy, 2020-2030 (US$ Million)
9.1.3.1.2.1 Brazil: Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy, 2020-2030 (US$ Million)
9.1.3.1.2.2 Brazil: Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy, 2020-2030 (US$ Million)
9.1.3.1.3 Brazil: Breast Cancer Therapeutics Market, by Breast Cancer Type, 2020-2030 (US$ Million)
9.1.3.1.4 Brazil: Breast Cancer Therapeutics Market, by Distribution Channel, 2020-2030 (US$ Million)
9.1.3.2 Argentina
9.1.3.2.1 Argentina Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
9.1.3.2.2 Argentina: Breast Cancer Therapeutics Market, by Drug Therapy, 2020-2030 (US$ Million)
9.1.3.2.2.1 Argentina: Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy, 2020-2030 (US$ Million)
9.1.3.2.2.2 Argentina: Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy, 2020-2030 (US$ Million)
9.1.3.2.3 Argentina: Breast Cancer Therapeutics Market, by Breast Cancer Type, 2020-2030 (US$ Million)
9.1.3.2.4 Argentina: Breast Cancer Therapeutics Market, by Distribution Channel, 2020-2030 (US$ Million)
9.1.3.3 Rest of South & Central America
9.1.3.3.1 Rest of South & Central America Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
9.1.3.3.2 Rest of South & Central America: Breast Cancer Therapeutics Market, by Drug Therapy, 2020-2030 (US$ Million)
9.1.3.3.2.1 Rest of South & Central America: Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy, 2020-2030 (US$ Million)
9.1.3.3.2.2 Rest of South & Central America: Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy, 2020-2030 (US$ Million)
9.1.3.3.3 Rest of South & Central America: Breast Cancer Therapeutics Market, by Breast Cancer Type, 2020-2030 (US$ Million)
9.1.3.3.4 Rest of South & Central America: Breast Cancer Therapeutics Market, by Distribution Channel, 2020-2030 (US$ Million)
10. Breast Cancer Therapeutics Market-Industry Landscape
10.1 Overview
10.2 Growth Strategies in Breast Cancer Therapeutics Market
10.3 Organic Growth Strategies
10.3.1 Overview
10.4 Inorganic Growth Strategies
10.4.1 Overview
11. Company Profiles
11.1 Eli Lilly and Co
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Products and Services
11.1.4 Financial Overview
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 Eisai Co Ltd
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Products and Services
11.2.4 Financial Overview
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 Novartis AG
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Products and Services
11.3.4 Financial Overview
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 AstraZeneca Plc
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Products and Services
11.4.4 Financial Overview
11.4.5 SWOT Analysis
11.4.6 Key Developments
11.5 Pfizer Inc
11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Products and Services
11.5.4 Financial Overview
11.5.5 SWOT Analysis
11.5.6 Key Developments
11.6 Gilead Sciences Inc
11.6.1 Key Facts
11.6.2 Business Description
11.6.3 Products and Services
11.6.4 Financial Overview
11.6.5 SWOT Analysis
11.6.6 Key Developments
11.7 Merck & Co Inc
11.7.1 Key Facts
11.7.2 Business Description
11.7.3 Products and Services
11.7.4 Financial Overview
11.7.5 SWOT Analysis
11.7.6 Key Developments
11.8 Teva Pharmaceutical Industries Ltd
11.8.1 Key Facts
11.8.2 Business Description
11.8.3 Products and Services
11.8.4 Financial Overview
11.8.5 SWOT Analysis
11.8.6 Key Developments
11.9 Amgen Inc
11.9.1 Key Facts
11.9.2 Business Description
11.9.3 Products and Services
11.9.4 Financial Overview
11.9.5 SWOT Analysis
11.9.6 Key Developments
12. Appendix
12.1 About Us
12.2 Glossary of Terms
List of Tables
Table 1. South & Central America Breast Cancer Therapeutics Market Segmentation
Table 2. South & Central America Breast Cancer Therapeutics Market, by Targeted Drug Therapy - Revenue and Forecast to 2030 (US$ Million)
Table 3. South & Central America Breast Cancer Therapeutics Market, by Hormonal Drug Therapy - Revenue and Forecast to 2030 (US$ Million)
Table 4. Brazil Breast Cancer Therapeutics Market, by Drug Therapy - Revenue and Forecast to 2030 (US$ Million)
Table 5. Brazil Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy - Revenue and Forecast to 2030 (US$ Million)
Table 6. Brazil Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy - Revenue and Forecast to 2030 (US$ Million)
Table 7. Brazil Breast Cancer Therapeutics Market, by Breast Cancer Type - Revenue and Forecast to 2030 (US$ Million)
Table 8. Brazil Breast Cancer Therapeutics Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
Table 9. Argentina Breast Cancer Therapeutics Market, by Drug Therapy - Revenue and Forecast to 2030 (US$ Million)
Table 10. Argentina Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy - Revenue and Forecast to 2030 (US$ Million)
Table 11. Argentina Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy - Revenue and Forecast to 2030 (US$ Million)
Table 12. Argentina Breast Cancer Therapeutics Market, by Breast Cancer Type - Revenue and Forecast to 2030 (US$ Million)
Table 13. Argentina Breast Cancer Therapeutics Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
Table 14. Rest of South & Central America Breast Cancer Therapeutics Market, by Drug Therapy - Revenue and Forecast to 2030 (US$ Million)
Table 15. Rest of South & Central America Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy - Revenue and Forecast to 2030 (US$ Million)
Table 16. Rest of South & Central America Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy - Revenue and Forecast to 2030 (US$ Million)
Table 17. Rest of South & Central America Breast Cancer Therapeutics Market, by Breast Cancer Type - Revenue and Forecast to 2030 (US$ Million)
Table 18. Rest of South & Central America Breast Cancer Therapeutics Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
Table 19. Recent Organic Growth Strategies in Breast Cancer Therapeutics Market
Table 20. Recent Inorganic Growth Strategies in the Breast Cancer Therapeutics Market
Table 21. Glossary of Terms, Breast Cancer Therapeutics Market
List of Figures
Figure 1. South & Central America Breast Cancer Therapeutics Market Segmentation, By Country
Figure 2. South & Central America Breast Cancer Therapeutics Market - Key Industry Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. South & Central America Breast Cancer Therapeutics Market Revenue (US$ Mn), 2022 - 2030
Figure 5. South & Central America Breast Cancer Therapeutics Market Revenue Share, by Drug Therapy, 2022 & 2030 (%)
Figure 6. Targeted Drug Therapy: South & Central America Breast Cancer Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 7. Hormonal Drug Therapy: South & Central America Breast Cancer Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 8. Chemotherapy: South & Central America Breast Cancer Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 9. Immunotherapy/ Biological Therapy: South & Central America Breast Cancer Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 10. South & Central America Breast Cancer Therapeutics Market Revenue Share, by Breast Cancer Type, 2022 & 2030 (%)
Figure 11. Hormone Receptor: South & Central America Breast Cancer Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 12. HER2+: South & Central America Breast Cancer Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 13. Triple-Negative Breast Cancer: South & Central America Breast Cancer Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 14. South & Central America Breast Cancer Therapeutics Market Revenue Share, by Distribution Channel, 2022 & 2030 (%)
Figure 15. Hospital Pharmacies: South & Central America Breast Cancer Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 16. Drug Store and Retail Pharmacies: South & Central America Breast Cancer Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 17. Online Pharmacies: South & Central America Breast Cancer Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 18. South & Central America Breast Cancer Therapeutics Market, by Key Country - Revenue (2022) (US$ Million)
Figure 19. South & Central America Breast Cancer Therapeutics Market, By Key Countries, 2022 and 2030 (%)
Figure 20. Brazil Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
Figure 21. Argentina Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
Figure 22. Rest of South & Central America Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
Figure 23. Growth Strategies in Breast Cancer Therapeutics Market
1. Eli Lilly and Co
2. Eisai Co Ltd
3. Novartis AG
4. AstraZeneca Plc
5. Pfizer Inc
6. Gilead Sciences Inc
7. Merck & Co Inc
8. Teva Pharmaceutical Industries Ltd
9. Amgen Inc
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the South & Central America breast cancer therapeutics market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in South & Central America breast cancer therapeutics market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth South & Central America market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution